|
NAPEPLD expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.560600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.061200E-01 |
| Normal-vs-Stage2 |
7.265800E-01 |
| Normal-vs-Stage3 |
1.772490E-04 |
| Normal-vs-Stage4 |
1.35670000012134E-07 |
| Stage1-vs-Stage2 |
4.907000E-01 |
| Stage1-vs-Stage3 |
2.336400E-03 |
| Stage1-vs-Stage4 |
4.52380000015573E-07 |
| Stage2-vs-Stage3 |
1.184750E-01 |
| Stage2-vs-Stage4 |
6.696000E-02 |
| Stage3-vs-Stage4 |
3.315400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.541250E-01 |
| Normal-vs-AfricanAmerican |
2.567200E-01 |
| Normal-vs-Asian |
1.240800E-01 |
| Caucasian-vs-AfricanAmerican |
7.469000E-01 |
| Caucasian-vs-Asian |
5.569800E-01 |
| AfricanAmerican-vs-Asian |
7.768800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.452030E-01 |
| Normal-vs-Female |
4.097800E-01 |
| Male-vs-Female |
9.477000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.057800E-03 |
| Normal-vs-Extreme_Weight |
1.695170E-01 |
| Normal-vs-Obese |
4.186400E-01 |
| Normal-vs-Extreme_Obese |
9.912000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.773640E-01 |
| Normal_Weight-vs-Obese |
1.619830E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.645000E-01 |
| Extreme_Weight-vs-Obese |
7.971400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.474200E-01 |
| Obese-vs-Extreme_Obese |
7.230400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.363820E-02 |
| Normal-vs-Age(41-60Yrs) |
4.907800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.560380E-01 |
| Normal-vs-Age(81-100Yrs) |
9.000200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.847900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.648580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.454400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.230800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.114600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.905400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.813600E-01 |
| Normal-VS-Type2 PRCC |
6.803700E-04 |
| Normal-VS-KIRP CIMP |
1.98740002232967E-09 |
| Normal-VS-Unclassified PRCC |
3.812800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.53569999999226E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.16715534406831E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
1.796630E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.078730E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.813900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.799570E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.183600E-03 |
| Normal-vs-N1 |
1.91205999999777E-05 |
| Normal-vs-N2 |
3.72709999996168E-06 |
| N0-vs-N1 |
1.367790E-01 |
| N0-vs-N2 |
9.356700E-03 |
| N1-vs-N2 |
5.927600E-01 |
|
|
